U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154485) titled 'Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia' on Aug. 12.
Brief Summary: The purpose of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics (PK/PD), immunogenicity, and efficacy of multiple intravenous administrations of the investigational drug NS101, compared to placebo, in patients with semantic variant primary progressive aphasia (svPPA), a subtype of frontotemporal dementia (FTD)
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Dementia Frontotemporal
Intervention:
DRUG: NS101 IV infusion
NS101 is anti FAM19A5 antibody expect...